Literature DB >> 25139670

Skeletal defects in Osterix-Cre transgenic mice.

Wei Huang1, Bjorn R Olsen.   

Abstract

Cre/loxP recombination is a powerful strategy widely used for in vivo conditional gene targeting. This technique has made possible many important discoveries of gene function in normal and disease biology. However, due to the transgenic nature of most Cre mouse strains undesired phenotypes occasionally occur in Cre mice. Here we report skeletal defects in Osterix-Cre (Osx-Cre) transgenic mice including delayed calvarial ossification and fracture calluses at multiple skeletal sites. These data suggest that Osx-Cre containing controls should be used for both in vivo and in vitro skeletal analyses of conditional knockout mice generated with this Osx-Cre mouse strain.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25139670      PMCID: PMC4276445          DOI: 10.1007/s11248-014-9828-6

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  19 in total

Review 1.  Cre/loxP recombination system and gene targeting.

Authors:  Ralf Kühn; Raul M Torres
Journal:  Methods Mol Biol       Date:  2002

2.  Decreased body weight in young Osterix-Cre transgenic mice results in delayed cortical bone expansion and accrual.

Authors:  Rachel A Davey; Michele V Clarke; Stephen Sastra; Jarrod P Skinner; Cherie Chiang; Paul H Anderson; Jeffrey D Zajac
Journal:  Transgenic Res       Date:  2011-12-13       Impact factor: 2.788

3.  Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development.

Authors:  Wei Zhu; Gang Liang; Zhiping Huang; Stephen B Doty; Adele L Boskey
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

4.  Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors.

Authors:  Stephen J Rodda; Andrew P McMahon
Journal:  Development       Date:  2006-07-19       Impact factor: 6.868

5.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

Review 6.  Germ-line transformation of mice.

Authors:  R D Palmiter; R L Brinster
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

7.  The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation.

Authors:  Kazuhisa Nakashima; Xin Zhou; Gary Kunkel; Zhaoping Zhang; Jian Min Deng; Richard R Behringer; Benoit de Crombrugghe
Journal:  Cell       Date:  2002-01-11       Impact factor: 41.582

Review 8.  Engineering chromosomal rearrangements in mice.

Authors:  Y Yu; A Bradley
Journal:  Nat Rev Genet       Date:  2001-10       Impact factor: 53.242

Review 9.  Insertional mutation of 'classical' and novel genes in transgenic mice.

Authors:  M H Meisler
Journal:  Trends Genet       Date:  1992-10       Impact factor: 11.639

10.  Osx-Cre targets multiple cell types besides osteoblast lineage in postnatal mice.

Authors:  Jianquan Chen; Yu Shi; Jenna Regan; Kannan Karuppaiah; David M Ornitz; Fanxin Long
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

View more
  31 in total

1.  Multiple essential MT1-MMP functions in tooth root formation, dentinogenesis, and tooth eruption.

Authors:  H Xu; T N Snider; H F Wimer; S S Yamada; T Yang; K Holmbeck; B L Foster
Journal:  Matrix Biol       Date:  2016-01-15       Impact factor: 11.583

2.  Rothmund-Thomson Syndrome-like RECQL4 truncating mutations cause a haploinsufficient low bone mass phenotype in mice.

Authors:  Wilson Castillo-Tandazo; Ann E Frazier; Natalie A Sims; Monique F Smeets; Carl R Walkley
Journal:  Mol Cell Biol       Date:  2020-12-23       Impact factor: 4.272

3.  The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation.

Authors:  Jinhu Xiong; Maria Almeida; Charles A O'Brien
Journal:  Bone       Date:  2018-04-04       Impact factor: 4.398

4.  Tgfbr2 is required in osterix expressing cells for postnatal skeletal development.

Authors:  Sarah B Peters; Ying Wang; Rosa Serra
Journal:  Bone       Date:  2016-12-30       Impact factor: 4.398

5.  FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth.

Authors:  Kannan Karuppaiah; Kai Yu; Joohyun Lim; Jianquan Chen; Craig Smith; Fanxin Long; David M Ornitz
Journal:  Development       Date:  2016-04-06       Impact factor: 6.868

6.  Tsc1 Regulates the Balance Between Osteoblast and Adipocyte Differentiation Through Autophagy/Notch1/β-Catenin Cascade.

Authors:  Han Kyoung Choi; Hebao Yuan; Fang Fang; Xiaoxi Wei; Lu Liu; Qing Li; Jun-Lin Guan; Fei Liu
Journal:  J Bone Miner Res       Date:  2018-07-19       Impact factor: 6.741

7.  Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation.

Authors:  Jun Tang; Jing Xie; Wei Chen; Chenyi Tang; Jinjin Wu; Yiping Wang; Xue-Dong Zhou; Hou-De Zhou; Yi-Ping Li
Journal:  J Biol Chem       Date:  2020-06-22       Impact factor: 5.157

8.  Conditional Activation of NF-κB Inducing Kinase (NIK) in the Osteolineage Enhances Both Basal and Loading-Induced Bone Formation.

Authors:  Jennifer L Davis; Linda Cox; Christine Shao; Cheng Lyu; Shaopeng Liu; Rajeev Aurora; Deborah J Veis
Journal:  J Bone Miner Res       Date:  2019-07-31       Impact factor: 6.741

9.  Calvarial bone development and suture closure in Dicer-deficient mice.

Authors:  P Atsawasuwan; M Ouibaidin; B Dalal; H Khan; A Mohammed
Journal:  Orthod Craniofac Res       Date:  2017-06       Impact factor: 1.826

10.  β-Catenin Directs Long-Chain Fatty Acid Catabolism in the Osteoblasts of Male Mice.

Authors:  Julie L Frey; Soohyun P Kim; Zhu Li; Michael J Wolfgang; Ryan C Riddle
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.